Aprogen Biologics Inc. (KRX:003060)

Aprogen Biologics Revenue

Aprogen Biologics had revenue of 21.12B KRW in the quarter ending September 30, 2025, with 45.33% growth. This brings the company's revenue in the last twelve months to 74.91B, up 10.11% year-over-year. In the year 2024, Aprogen Biologics had annual revenue of 67.38B, down -22.88%.

• Revenue (ttm): 74.91B
• Revenue Growth: +10.11%
• P/S Ratio: 1.42
• Revenue / Employee: 191.59M
• Employees: 391
• Market Cap: 106.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	67.38B	-19.99B	-22.88%
Dec 31, 2023	87.36B	22.17B	34.01%
Dec 31, 2022	65.19B	8.71B	15.42%
Dec 31, 2021	56.48B	3.16B	5.93%
Dec 31, 2020	53.32B	2.42B	4.75%